1 in 8 Women of reproductive age have PCOS, making it the most common hormonal disorder. Which means you're not alone
70% Of women with PCOS have insulin resistance, the underlying mechanism both treatments target. But insulin resistance looks different in different women
2023 Year the International PCOS Guideline formally included myo-inositol for the first time. Before this, only metformin had official backing

The mechanisms: where they differ

Metformin is a prescription drug originally designed for type 2 diabetes. It stops your liver from pumping out glucose and makes your cells more responsive to insulin at the cellular level.

Inositol (specifically myo-inositol in a 40:1 ratio with D-chiro-inositol, based on newer research) works downstream of the insulin receptor itself. It helps your cells grab glucose from the bloodstream more effectively. They work through different pathways. Which means some doctors have explored using both together, but you shouldn't try that without medical supervision.

Research Note

A 2023 systematic review and meta-analysis comparing inositol to metformin in women with PCOS found both produced significant improvements in fasting insulin and HOMA-IR (a measure of insulin resistance). Inositol showed comparable improvements to metformin on cycle regularity and androgen levels in several head-to-head trials, with a significantly lower rate of gastrointestinal side effects.

What the evidence actually shows

Metformin has the longer track record. Decades of trials show it improves insulin resistance, gets your period regular, lowers androgens, and helps you ovulate. It's also got the strongest data for people trying to get pregnant. Some studies even suggest it may reduce miscarriage risk in early PCOS pregnancies.

Inositol has accumulated solid evidence, especially for egg quality, cycle regularity, and lowering androgens. In 2023, the international PCOS guideline formally recognized myo-inositol for irregular periods. It's now on equal footing with metformin for that specific outcome. But evidence for blood pressure and cholesterol is thinner than metformin's.

Key Difference

Metformin commonly causes nausea, diarrhoea, and bloating. Particularly at initiation. These side effects are dose-dependent and often reduce over time, but they lead many women to discontinue. Inositol is generally well tolerated and available without prescription. Though this also means it lacks the regulatory oversight of a licensed medication.

Which one might be right for you

Metformin gets picked when your insulin resistance is serious, when your glucose or cholesterol are concerning, or when you're planning to get pregnant. Especially if you need help ovulating. It's been around for decades with a solid safety track record.

Inositol makes sense if metformin's GI side effects make you miserable, if egg quality for IVF is your main focus, or as an add-on to other treatments. Most women assume either one of these is the answer. Neither beats lifestyle changes, which remain the first-line move in PCOS according to every guideline. This matters because it's where your effort should focus first.

What to ask your doctor

🩺

This is a decision to make with your doctor

Both inositol and metformin affect insulin signalling and should be used with medical oversight. Metformin is a prescription medication. It should not be obtained without a clinical assessment. Inositol is available as a supplement, but self-prescribing for a diagnosed condition without monitoring is not advisable. Ask for a PCOS specialist referral if your doctor is not up to date on current guideline recommendations.

Medical Disclaimer: This article is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

  1. Teede HJ, Tay CT, Laven J, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-2469. PubMed
  2. Unfer V, Nestler JE, Kamenov ZA, et al. Effects of Inositols in Women with PCOS: A Systematic Review of Randomized Controlled Trials. Int J Endocrinol. 2016;2016:1849162. PubMed
  3. Regidor PA, Schindler AE. Myo-Inositol as a Safe and Promising Therapeutic Agent for the Treatment of PCOS. Front Endocrinol. 2021;12:engine. doi:10.3389/fendo.2021.609554